Literature DB >> 188369

Changes of cyclic-AMP and cycic-AMP phosphodiesterase in the progression and regression of experimental atherosclerosis.

F Numano, H Maezawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 188369     DOI： 10.1111/j.1749-6632.1976.tb43363.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation.

Authors:  A Dembinska-Kiec; W Rücker; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

2.  PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.

Authors:  A Dembinska-Kiec; W Rücker; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

3.  Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

Authors:  O R Etingin; D P Hajjar
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

4.  Cyclic AMP: a potent inhibitor of DNA synthesis in cultured arterial endothelial and smooth muscle cells.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.